Early Metformin Use Lowers Long COVID Risk, Finds Study Medha Baranwal6 Sept 2025 8:45 AM ISTUK: A large UK target trial emulation using COVID-OUT trial data found that early use of metformin reduced the risk of long COVID by 36% at 1 year...
GLP-1 Receptor Agonists Improve Metabolic Outcomes in Schizophrenia Patients on Antipsychotics: JAMA Medha Baranwal6 Sept 2025 8:30 AM ISTDenmark: Researchers have found in a new randomized HISTORI trial that schizophrenia patients on antipsychotics experienced greater weight loss and...
Medical Bulletin 04/September/2025 Anshika Mishra4 Sept 2025 3:00 PM ISTHere are the top medical news for the day:Hepatitis B Vaccine May Lower Diabetes Risk: Study FindsA new study to be presented at the Annual Meeting of...
Women With Metabolic Syndrome Face Higher Odds of Overactive Bladder: Study Medha Baranwal4 Sept 2025 9:15 AM ISTChina: A recent study published in Diabetology & Metabolic Syndrome has highlighted a strong link between metabolic syndrome (MetS) and the...
Weight Loss Drugs May Lower Risk of Heart Failure Hospitalization and Death by 40 Percent: Study Anshika Mishra4 Sept 2025 8:30 AM ISTA new large-scale study published in JAMA and presented at the European Society of Cardiology Congress reveals that glucagon-like peptide-1 (GLP-1)...
HOMA-IR Identified as Independent Predictor of Liver Fibrosis in MAFLD, suggests study Dr Riya Dave4 Sept 2025 8:15 AM ISTAccording to a recent study published in Scientific Reports insulin resistance as assessed by the homeostatic model assessment for insulin resistance...
Treating Heart Failure with Anti-Obesity Medication: Dual Benefits for Clinical Outcomes and Climate Impact Dr. Kamal Kant Kohli2 Sept 2025 8:30 AM ISTNew research has found that the use of GLP-1 receptor agonists*, a class of medications commonly prescribed for patients with obesity and diabetes,...
ATTAIN-2 Trial: Oral GLP-1 Orforglipron Lowers Weight and HbA1c among diabetics with obesity Dr. Kamal Kant Kohli28 Aug 2025 12:00 PM ISTTopline results from the ATTAIN-2 trial have demonstrated that adults taking 36 mg orforglipron lost an average of 10.5% body weight at 72 weeks,...
Type 2 diabetes blood factors drive breast cancer aggression, finds BU study Dr. Kamal Kant Kohli27 Aug 2025 9:00 PM ISTPeople with type 2 obesity-driven diabetes tend to have more aggressive breast cancers, but no one knows exactly why. A new study by researchers at...
Medical Bulletin 26/August/2025 Anshika Mishra26 Aug 2025 3:00 PM ISTHere are the top medical news for the day:Study Reveals Your Brain Burns Fat at Night to Prevent Sugar CrashesA recent study published in Molecular...
New Study Discovers Fat-Trapping Green Tea Beads for Safe Weight Loss Anshika Mishra26 Aug 2025 8:15 AM ISTA recent study presented at the ACS Fall 2025 Digital Meeting by researchers from Sichuan University has developed edible microbeads made from green...
GLP-1RA Use May Lower Overall Cancer Risk but Increase Kidney Cancer Risk in Obese Patients: JAMA Medha Baranwal25 Aug 2025 11:00 AM ISTUSA: A new study published in JAMA Oncology has revealed that glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely used for type 2 diabetes...
